Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NVAX
#2204
Novavax, Inc. - Common Stock
8.9
1
USD
-0.05%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-4.50%
Monthly Change
-2.84%
6 month change
+10.82%
Year Change
+26.92%
Previous Close
9.3
3
Open
8.9
1
Low
8.9
1
High
8.9
1
Volume
148
Markets
US Stock Market
Healthcare
Biotechnology
NVAX
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
73.86 M
76.28 M
86.17 M
139.95 M
160.84 M
162.94 M
164.44 M
Valuation ratios
Enterprise value
8.11 B
9.85 B
25.3 M
308.62 M
939.65 M
1.1 B
1.32 B
Price to earnings ratio
—
-6.1
-1.16
-0.93
-6.54
2.6
-22.9
Price to sales ratio
—
9.29
0.39
0.52
1.79
1.04
2.69
Price to cash flow ratio
—
32.96
-1.84
0.71
14.02
-4.76
-19.49
Price to book ratio
—
-30.27
-1.21
0.71
1.96
-9.11
-3.95
Enterprise value to EBITDA ratio
-19.67
-5.89
-0.04
-0.59
-4.68
2.29
—
Profitability ratios
Return on assets %
-0.26
-0.68
-0.29
-0.3
-0.12
0.37
-0.01
Return on equity %
-0.67
4.96
1.04
0.76
0.3
-3.45
0.07
Return on invested capital %
-590.32
-485.21
-121.46
-113.76
-60.39
342.59
-14.62
Gross margin %
100
100
54.46
65.05
70.28
93.5
78
Operating margin %
-87.62
-147.13
-32.53
-57.59
-36.49
40.3
-11.06
EBITDA margin %
-86.72
-146.04
-31.06
-53.42
-29.46
42.8
—
Net margin %
-87.94
-152.12
-33.2
-55.41
-27.49
39.19
-6.8
Liquidity ratios
Quick ratio
—
—
0.68
0.67
0.97
2.1
2.45
Current ratio
2.15
0.9
0.69
0.7
0.98
2.13
2.48
Inventory turnover
—
—
2.09
-0.03
1.13
0.19
0.37
Asset turnover
0.54
0.55
0.82
0.49
0.41
0.82
0.13
Solvency ratios
Debt to assets ratio
0.27
0.18
0.23
0.1
0.11
0.21
—
Debt to equity ratio
0.68
-1.29
-0.82
-0.24
-0.28
-1.93
—
Long term debt to total assets ratio
0.2
0.13
-0
-0
-0
-0.01
0.28
Long term debt to total equity ratio
0.51
-0.92
0.01
0.01
0.01
0.06
-2.01
Per share metrics
Operating cash flow per share
—
4.34
-5.32
-7.09
-0.57
-1.41
-0.48
EBIT per share
—
-22.67
-8.25
-5.62
-1.64
2.62
-0.54
EBITDA per share
—
-22.5
-7.87
-5.22
-1.32
2.78
—
Total debt per share
—
6.1
6.63
1.72
1.16
1.43
—
Cash per share
—
20.36
17.1
5.64
6.07
4.25
4.84
Net current asset value per share
—
28.97
21.79
11.35
7.42
5.65
5.21
Tangible book value per share
—
-4.73
-8.11
-7.11
-4.1
-0.74
-0.89
Working capital per share
—
-3.16
-9.68
-4.88
-0.17
2.99
3.11
Book value per share
—
-4.73
-8.11
-7.11
-4.1
-0.74
-0.89
News
FBRX Stock Rallies 78% on Positive Early-Stage Vitiligo Study Data
TVRD Stock Rallies 149% So Far This Week: Here's What You Should Know
Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights
ZTS Wins European Commission Approval for New Poultry Disease Vaccine
AtaiBeckley Completes VLS-01 Dosing in Phase IIb Depression Study
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Novavax (NVAX) Stock Moves 1.36%: What You Should Know
Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know